Dai Ichi Life Holdings Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,578 shares of the healthcare conglomerate’s stock after selling 26,122 shares during the period. Dai Ichi Life Holdings Inc.’s holdings in UnitedHealth Group were worth $17,581,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Gerstein Fisher raised its position in UnitedHealth Group by 4.3% in the third quarter. Gerstein Fisher now owns 6,927 shares of the healthcare conglomerate’s stock worth $970,000 after buying an additional 285 shares during the period. Picton Mahoney Asset Management raised its position in UnitedHealth Group by 1.6% in the third quarter. Picton Mahoney Asset Management now owns 158,975 shares of the healthcare conglomerate’s stock worth $22,257,000 after buying an additional 2,515 shares during the period. Laurel Wealth Advisors Inc. raised its position in UnitedHealth Group by 5.3% in the third quarter. Laurel Wealth Advisors Inc. now owns 2,022 shares of the healthcare conglomerate’s stock worth $283,000 after buying an additional 101 shares during the period. Cetera Advisor Networks LLC raised its position in UnitedHealth Group by 60.4% in the third quarter. Cetera Advisor Networks LLC now owns 19,034 shares of the healthcare conglomerate’s stock worth $2,665,000 after buying an additional 7,170 shares during the period. Finally, Cetera Investment Advisers acquired a new position in UnitedHealth Group during the third quarter worth $279,000. 86.54% of the stock is currently owned by institutional investors and hedge funds.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.19% during midday trading on Friday, reaching $160.75. 1,905,884 shares of the company were exchanged. The company has a market capitalization of $152.90 billion, a PE ratio of 22.17 and a beta of 0.68. The stock’s 50-day moving average price is $161.21 and its 200-day moving average price is $148.35. UnitedHealth Group Incorporated has a 52-week low of $112.53 and a 52-week high of $164.00.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 17th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.04. The company had revenue of $47.50 billion for the quarter, compared to the consensus estimate of $47.12 billion. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. UnitedHealth Group’s revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.40 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post $9.51 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 21st. Shareholders of record on Friday, March 10th will be paid a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date of this dividend is Wednesday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 33.47%.
TRADEMARK VIOLATION NOTICE: “Dai Ichi Life Holdings Inc. Cuts Stake in UnitedHealth Group Incorporated (UNH)” was posted by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another website, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at http://sleekmoney.com/dai-ichi-life-holdings-inc-cuts-stake-in-unitedhealth-group-incorporated-unh/1657000.html.
A number of research firms have weighed in on UNH. Vetr lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Friday. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, February 7th. Cantor Fitzgerald began coverage on shares of UnitedHealth Group in a research report on Monday, February 6th. They set an “overweight” rating and a $200.00 price target on the stock. Leerink Swann reaffirmed an “outperform” rating and set a $185.00 price target on shares of UnitedHealth Group in a research report on Tuesday, January 24th. Finally, Argus reaffirmed a “buy” rating and set a $170.00 price target on shares of UnitedHealth Group in a research report on Monday, January 23rd. One equities research analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $175.41.
In other news, Director Richard T. Burke sold 45,000 shares of the firm’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $158.66, for a total value of $7,139,700.00. Following the transaction, the director now owns 1,944,949 shares of the company’s stock, valued at approximately $308,585,608.34. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Tuesday, January 31st. The shares were sold at an average price of $161.68, for a total transaction of $1,616,800.00. Following the completion of the transaction, the director now directly owns 1,921,191 shares in the company, valued at approximately $310,618,160.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 75,460 shares of company stock worth $11,975,503. 1.65% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/dai-ichi-life-holdings-inc-cuts-stake-in-unitedhealth-group-incorporated-unh/1657000.html
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.